임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 예정· DRESS Syndrome약물에 대한 심각한 과민반응(DRESS 증후군)의 치료를 위한 표적치료의 유용성
Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome)
협력: 아스트라제네카
- 2상모집 예정· Non-small Cell Lung CancerThe Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2
협력: 아스트라제네카
- 2상모집 예정· Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 PositiveA Phase 2 Study of ABSK043 Combined With Osimertinib
협력: 아스트라제네카
- 2상모집 예정· Colorectal CancerA Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
협력: 아스트라제네카, 일라이 릴리
- 2상모집 예정· Combined Hepatocellular and CholangiocarcinomaA Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
협력: 아스트라제네카
- 2상모집 예정· Esophagogastric AdenocarcinomaTNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma
협력: 아스트라제네카
- 2상모집 중· Non-Small Cell Lung CancerPneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Transthyretin Amyloid Cardiomyopathy (ATTR-CM)A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM
리드: 아스트라제네카
- 2상모집 중· Idiopathic Pulmonary Fibrosis (IPF)A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
리드: 아스트라제네카
- 2상모집 중· Chronic Lymphocytic Leukemia (CLL)Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
- 2상모집 중· Advanced Breast CancerStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
리드: 아스트라제네카
- 2상모집 중· Antiphospholipid Syndrome (APS)Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
협력: 아스트라제네카
- 2상모집 중· Adenoid Cystic CarcinomaPhase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)
협력: 아스트라제네카
- 2상모집 예정· Metastatic HR+/HER2- Breast CancerRash & Diarrhea Prophylaxis With Capivasertib
협력: 아스트라제네카
- 2상모집 중· Primary Membranous NephropathyA Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
리드: 아스트라제네카
- 2상모집 중· Non-Small Cell Lung CancerA Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
협력: 아스트라제네카
- 2상모집 중· Small Cell Lung Cancer (SCLC)Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
협력: 아스트라제네카
- 2상모집 중· Intrahepatic CholangiocarcinomaA Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
협력: 아스트라제네카
- 2상모집 중· Rheumatoid ArthritisA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
리드: 아스트라제네카
- 2상모집 중· Clostridioides Difficile InfectionPrevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody
리드: 아스트라제네카
- 2상모집 중· Chronic Kidney Disease and HypertensionA Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
리드: 아스트라제네카
- 2상모집 중· Bronchiectasis With Pseudomonas Aeruginosa ColonizationA Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
리드: 아스트라제네카
- 2상모집 중· Triple Negative Breast CancerInvestigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer
협력: 아스트라제네카
- 2상모집 중· Hepatocellular CarcinomaSTRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma
협력: 아스트라제네카
- 2상모집 중· Colorectal CancerUpfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.
협력: 아스트라제네카
- 2상모집 중· Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
협력: 아스트라제네카
- 2상모집 중· Primary Membranous NephropathyStudy of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
협력: 아스트라제네카
- 2상모집 중· Mantle-cell LymphomaA Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
리드: 아스트라제네카
- 2상모집 예정· Advanced Solid TumorMEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.
협력: 아스트라제네카
- 2상모집 중· Non-Small Cell Lung CancerA Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Hepatocellular CarcinomaDurvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma
리드: 아스트라제네카
- 2상초청 등록· Breast Cancer MetastaticDetecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy
협력: 아스트라제네카
- 2상모집 중· Gastroesophageal AdenocarcinomaA Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
리드: 아스트라제네카
- 2상모집 중· Chronic Obstructive Pulmonary Disease (COPD)A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
리드: 아스트라제네카
- 2상모집 중· Breast Cancer MetastaticTrial of Trastuzumab Deruxtecan in Previously Treated HER2
협력: 아스트라제네카
- 2상모집 중· Advanced Intrahepatic CholangiocarcinomaHYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
협력: 아스트라제네카
- 2상모집 중· Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaAcalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Obesity/OverweightThis is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
리드: 아스트라제네카
- 2상모집 중· Chronic Kidney Disease With High ProteinuriaA Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High Proteinuria
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Locally Advanced Cervical CancerA Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)
리드: 아스트라제네카
- 2상모집 중· Metastatic Colorectal CancerA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
리드: 아스트라제네카
- 2상모집 중· APOL1-Mediated Kidney DiseaseDose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
리드: 아스트라제네카
- 2상모집 중· Non-muscle Invasive Bladder CancerA Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Crohn's DiseaseStudy Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy
리드: 아스트라제네카
- 2상모집 중· CCCA Assessed by Ki67 Drop Below <2.7% From BaselineCapivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
협력: 아스트라제네카
- 2상모집 중· Hepatocellular CarcinomaStudy of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
협력: 아스트라제네카
- 2상모집 중· B-cell Non-Hodgkin LymphomaSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
리드: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.